Wartime research on malaria chemotherapy

Parassitologia

Volumn 42, Issue 1-2, 2000, Pages 33-45

  Sweeney, A W ^a,b  

^a SECRETARIAT OF THE PACIFIC COMMUNITY   (New Caledonia)

^b NONE   (Australia)

Author keywords

Antimalarial drugs; Atebrin; Chloroquine; Clinical trials; Malaria research; Paludrine; Quinine; World War II

Indexed keywords

ANTIMALARIAL AGENT;

ARTICLE; AUSTRALIA; DRUG SCREENING; HISTORY; HUMAN; HUMAN EXPERIMENT; MALARIA; RESEARCH; SOLDIER; UNITED KINGDOM; UNITED STATES; WAR;

ANTIMALARIALS; AUSTRALIA; DRUG EVALUATION, PRECLINICAL; GREAT BRITAIN; HISTORY, 20TH CENTURY; HUMAN EXPERIMENTATION; HUMANS; MALARIA; MILITARY PERSONNEL; RESEARCH; UNITED STATES; WAR;

EID: 0034208236     PISSN: 00482951     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. History of the Great War: based on official documents, medical services, diseases of the war. Vol 1, Ch IX Malaria, pp 227-246.
2. History of the Great War: based on official documents, military operations, Macedonia, from the spring of 1917 to the end of the war, p 294.
3. Schulman W (1932). Synthetic antimalarial preparations. J Proc Roy Soc Med 25: 897-904.
4. Kikuth W, Sioli P (1932). Further developments in synthetically produced drugs for malariatherapy, atebrin [title translated from German]. Dtsch med Wschr 58: 530-531.
5. Malaria Commission (1937). Fourth general report. Therapeutics of malaria. Bull Hlth Org League of Nations 6: 1011-1012.
6. Anonymous (1940). A brief review of needed research in malaria. Public Health Rep 55: 1801-1809.
7. Clark WM (1946) History of the Cooperative Wartime Program. In: A survey of antimalarial drugs, 1941-1945 (Wiselogle FY, ed). Ann Arbor, Michigan, pp 1-28.
8. National Academy of Sciences, Washington DC, USA [hereafter NAS] (1941). Conference on Chemotherapy of malaria. Minutes of third meeting, 13 October 1941: Memorandum on research in malarial chemotherapy, by Dr EK Marshall.
9. NAS (1942). Conference on Chemotherapy of malaria. Minutes of meeting, 20 June 1942.
10. Shute PG (1958). Thirty years of malaria therapy. J Trop Med Hyg 61: 57-61.
11. NAS (1944). Conference for a review of the malaria research program 29 March 1944, exhibit 1: report on a consideration of the rationale of the clinical testing program (antimalarials) by Dr James A Shannon.
12. Coatney GR, Cooper WC, Ruhe DS (1948). Studies in human malaria. VI. The organization of a program for testing potential antimalarial drugs in prisoner volunteers. Am J Hyg 47: 113-119.
13. Coatney GR (1963). Pitfalls in a discovery: the chronicle of chloroquine. Am J Trop Med Hyg 12: 121-128.
14. NAS (1944). Board for coordination of malarial studies. Appendix to minutes of meeting, 4 March 1944.
15. Fenner F, Sweeney AW (1998). Malaria in New Guinea during the Second World War: the Land Headquarters Medical Research Unit. Parassitologia 40: 65-68.
16. Fairley NH, Andrew RR, Blackburn CRB, Mackerras MJ, Roberts FHS, Allman SLW, Backhouse TC, Gregory TS, Pope KG, Dunn SR (1945). Chemotherapeutic suppression and prophylaxis in malaria: an experimental investigation undertaken by medical research teams in Australia. Trans R Soc Trop Med Hyg 38: 311-365.
17. NAS (1944). Minutes of meeting of panel on pharmacology of antimalarials, 26 May 1944.
18. NAS (1944). Minutes of meeting of panel on clinical testing, 31 Jan 1944.
19. Smith J (1941). The transfusion of whole blood. Aust NZ J Surgery 10: 384-392.
20. Fairley NH, Blackburn CRB, Andrew RR, Mackerras MJ, Roberts FHS, Allman SLW, Gregory TS, Backhouse TC, Tonge JI, Black RH, Lemerle TH, Ercole QN, Pope KG, Dunn SR, Swan MSA, Akhurst TAF, Roberts EM (1947). Sidelights on malaria in man obtained by subinoculation experiments. Trans R Soc Trop Med Hyg 40: 621-676.
21. Greenwood D (1995). Conflicts of interest: the genesis of synthetic antimalarial agents in peace and war. J Antimicrob Chemother 36: 857-872.
22. Curd FHS, Davey DG, Rose FL (1945). Studies on synthetic antimalarial drugs. II. General chemical considerations. Ann Trop Med Parasitol 39: 157-164.
23. Australian Academy of Sciences [hereafter AAS] (1945). Fairley papers. M4430. Summary of information: ICI report BT1085 by DG Davey dated 19 Feb 1945.
24. AAS (1945). Fairley papers. M4888. Summary of information: ICI report BT1086 by DG Davey dated 19 Feb 1945.
25. AAS (1945). Fairley papers, folder 65/9/44: letter Fairley to DGMS dated 24 Feb 1945.
26. AAS (1945). Fairley papers, folder 65/12/1: statement from Dr DG Davey.
27. AAS (1945). Fairley papers, folder 65/19/9: notebook with diary notes of visit to United States, Oct-Nov 1944.
28. NAS (1944). Minutes of meeting of panel of clinical testing, 10 Nov 1944.
29. Sinton JA, Smith S, Pottinger D (1930). Studies in malaria, with special reference to treatment. Part XII. Further research into the treatment of chronic benign tertian malaria with plasmoquine and quinine. Ind J Med Res 17: 793-814.
30. Malaria Commission (1933). Third general report: Therapeutics of malaria. Bull Hlth Org League of Nations 2: 185-285.
31. AAS. Unpublished report of the LHQ Medical Research Unit. The antimalarial activity of plasmoquine in volunteers exposed to experirnenal mosquito-transmitted malaria (New Guinea strains).
32. Sweeney AW (1997). The malaria frontline. Med J Aust 166: 316-319.
33. Ehrman FC, Ellis JM, Young MD (1945). Plasmodium vivax Chesson strain. Science 101: 377.
34. NAS (1945). Minutes of panel of review, 25 May 1945.
35. Berliner RW, Taggart JV, Zubrod G, Welch WJ, Earle DP, Shannon JA (1946). Pamaquin. 1. Curative antimalarial activity in vivax malaria. Fed Proc 5: 165.
36. Carson PE, Flanagan CL, Ickes LE, Alving AL (1956). Enzymatic deficiency in primaquine sensitive erythrocytes. Science 124: 484-485.
37. NAS (1945). Minutes of panel on pharmacology, 3 July 1945.
38. NAS (1946). Malaria report 723: clinical testing of antimalarial drugs, final report, by AS Alving, 31 Aug 1946.
39. Schmidt LH, Fradkin R, Genther CS, Hughes HB (1982). Delineation of the potentials of primaquine as a radical curative and prophylactic drug. Am J Trop Med Hyg 31 (3) Suppl: 666-680.
40. Arnold J, Alving AS, Hockwald RS, Clayman CB, Dern RJ, Beutler E, Jeffrey CM (1954). The effect of continuous and intermittent primaquine therapy on the relapse rate of Chesson strain vivax malaria. J Lab Clin Med 44: 429-438.
41. Australian Archives, Victoria, Dept of Defence (III). Army Headquarters: Correspondence files. Multiple number series, 1943-1951. MP742/1 211/6/1114 Australian Army Adjutant General, memo 20028 dated 12/2/45.
42. Fairley NH, Blackburn CRB, Mackerras IM, Gregory TS, Black RH, Lemerle TH, Ercole QN, Pope KG, Dunn SR, Swan MSA, Akhurst TAF, MacDonald IC, Tonge JI (1946). Atebrin susceptibility of the Aitape-Wewak strains of P. falciparum and P. vivax. A field and experimental investigation by LHQ Medical Research Unit. Trans R Soc Trop Med Hyg 40: 229-273.
43. Sweeney AW (1996). The possibility of an "X" factor. The first documented drug resistance of human malaria. Int J Parasitol 26: 1035-1061.
44. Edeson JFB, Field JW (1950). Proguanil-resistant falciparum malaria in Malaya. Br Med J 1: 147-151.
45. Payne D (1988). Spread of chloroquine resistance in Plasmodium falciparum. Parasitol Today 3: 241-246.
46. Karwacki JJ, Webster HK, Limsongwong N, Shanks GD (1989). Two cases of mefloquine resistant malaria in Thailand. Trans R Soc Trop Med Hyg 83: 152-153.